Track topics on Twitter Track topics that are important to you
Cempra, Inc., a clinical-stage pharmaceutical company focused on developing differentiated anti-infectives for acute care and community settings to meet critical medical needs in the treatment of infectious diseases, and Melinta Therapeutics, a privately held company focused on discovering, developing and commercializing novel antibiotics to treat serious bacterial infections, have announced that the companies have entered into […]
The post Cempra, Melinta merge to form commercial-stage anti-infectives company appeared first on CenterWatch News Online.
Original Article: Cempra, Melinta merge to form commercial-stage anti-infectives companyNEXT ARTICLE
Alternative Medicine Cleft Palate Complementary & Alternative Medicine Congenital Diseases Dentistry Ear Nose & Throat Food Safety Geriatrics Healthcare Hearing Medical Devices MRSA Muscular Dyst...